Early research (Phase 1)Ended earlyNCT03884829
What this trial is testing
A Phase I Study of CYC140, a PLK-1 Inhibitor, in Advanced Leukemias or MDS
Who this might be right for
AML, AdultMyelodysplastic SyndromesALL, Adult+2 more
Cyclacel Pharmaceuticals, Inc. 7